Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis

The Lancet Neurology

Volumn 9, Issue 2, 2010, Pages 149-158

  Tang, Chris C ^a   Poston, Kathleen L ^a,b,d   Eckert, Thomas ^a,c   Feigin, Andrew ^a   Frucht, Steven ^d   Gudesblatt, Mark ^f   Dhawan, Vijay ^a,g   Lesser, Martin ^a   Vonsattel, Jean Paul ^e   Fahn, Stanley ^d   Eidelberg, David ^a,g  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d NEUROLOGICAL INSTITUTE   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f South Shore Neurologic Associates   (United States)

^g NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA PLUS LEVODOPA; DOPAMINE RECEPTOR STIMULATING AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; AUTOMATION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FEMALE; HUMAN; IDIOPATHIC DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; NEUROIMAGING; PARKINSON DISEASE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME; VALIDATION PROCESS;

AGED; BRAIN; BRAIN MAPPING; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PARKINSONIAN DISORDERS; PATTERN RECOGNITION, AUTOMATED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 76249130565     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70002-8     Document Type: Article

References (31)

1. Hughes A.J., Ben-Shlomo Y., Daniel S.E., and Lees A.J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 57 (2001) S34-S38
2. Hughes A.J., Daniel S.E., Ben-Shlomo Y., and Lees A.J. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 125 (2002) 861-870
3. Shih L.C., and Tarsy D. Deep brain stimulation for the treatment of atypical parkinsonism. Mov Disord 22 (2007) 2149-2155
4. Deuschl G., Schade-Brittinger C., Krack P., et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 355 (2006) 896-908
5. Parkinson Study Group. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA 287 (2002) 1653-1661
6. Jankovic J., Rajput A.H., McDermott M.P., and Perl D.P. The evolution of diagnosis in early Parkinson disease. Arch Neurol 57 (2000) 369-372
7. Fahn S., Oakes D., Shoulson I., et al. Levodopa and the progression of Parkinson's disease. N Engl J Med 351 (2004) 2498-2508
8. Gaenslen A., Unmuth B., Godau J., et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol 7 (2008) 417-424
9. Vlaar A.M., de Nijs T., van Kroonenburgh M.J., et al. The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans. BMC Neurol 8 (2008) 42
10. Seppi K., Scherfler C., Donnemiller E., et al. Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis. Arch Neurol 63 (2006) 1154-1160
11. Brooks D.J., and Seppi K. Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Mov Disord 24 (2009) 949-964
12. Chung E.J., Lee W.Y., Yoon W.T., Kim B.J., and Lee G.H. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from parkinsonism-predominant multiple system atrophy. Mov Disord 24 (2009) 1650-1655
13. Eckert T., Tang C., and Eidelberg D. Assessment of the progression of Parkinson's disease: a metabolic network approach. Lancet Neurol 6 (2007) 926-932
14. Eidelberg D. Metabolic brain networks in neurodegenerative disorders: a functional imaging approach. Trends Neurosci 32 (2009) 548-557
15. Ma Y., Tang C., Spetsieris P.G., Dhawan V., and Eidelberg D. Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. J Cereb Blood Flow Metab 27 (2007) 597-605
16. Eckert T., Tang C., Ma Y., et al. Abnormal metabolic networks in atypical parkinsonism. Mov Disord 23 (2008) 727-733
17. Eckert T., Feigin A., Lewis D.E., Dhawan V., Frucht S., and Eidelberg D. Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging. Mov Disord 22 (2007) 167-173
18. Spetsieris P.G., Ma Y., Dhawan V., and Eidelberg D. Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features. Neuroimage 45 (2009) 1241-1252
19. Litvan I., Bhatia K.P., Burn D.J., et al. Movement Disorders Society scientific issues committee report: SIC task force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord 18 (2003) 467-486
20. Fahn S., and Jankovic J. Parkinsonism-plus syndromes and secondary parkinsonian disorders. Principles and practice of movement disorders (2007), Elsevier Health Sciences, New York 233-284
21. Schrag A., Ben-Shlomo Y., and Quinn N.P. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 354 (1999) 1771-1775
22. Papp M.I., and Lantos P.L. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 117 (1994) 235-243
23. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., and Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24 (2003) 197-211
24. Litvan I., Hauw J.J., Bartko J.J., et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55 (1996) 97-105
25. Allison P.D. Logistic regression using the SAS system: theory and application (1999), SAS Institute Inc, Cary
26. Hastie T., Tibshirani R., and Friedman J. Model assessment and selection-the elements of statistical learning: data mining, inference, and prediction. 2nd edn. (2009), Springer, New York 219-260
27. Osaki Y., Wenning G.K., Daniel S.E., et al. Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?. Neurology 59 (2002) 1486-1491
28. Osaki Y., Ben-Shlomo Y., Lees A.J., et al. Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord 19 (2004) 181-189
29. Wenning G.K., Ben-Shlomo Y., Hughes A., Daniel S.E., Lees A., and Quinn N.P. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?. J Neurol Neurosurg Psychiatry 68 (2000) 434-440
30. Huang C., Tang C., Feigin A., et al. Changes in network activity with the progression of Parkinson's disease. Brain 130 (2007) 1834-1846
31. Poston K., Tang C., Eckert T., Ma Y., Frucht S., and Eidelberg D. Longitudinal changes in regional metabolism and network activity in multiple system atrophy. Neurology 72 (2009) A67